Literature DB >> 31529178

Fibrosis-4 index reflects right-sided filling pressure in patients with heart failure.

Daichi Maeda1, Kazushi Sakane1, Takahide Ito1, Yumiko Kanzaki1, Koichi Sohmiya1, Masaaki Hoshiga2.   

Abstract

The fibrosis-4 index (FIB-4 index) is a marker of liver fibrosis. It has been reported that the FIB-4 index in compensated phase is associated with estimated right-sided filling pressure and poor prognosis in patients with heart failure. However, the relationship with invasively obtained right-sided cardiac pressures has been unclear. Hemodynamic status was evaluated by right heart catheterization in 189 heart failure patients who were in a clinically compensated phase between January 2015 and September 2017. Patients were assigned to two groups based on a median FIB-4 index of 2.15, then hemodynamic parameters and event rates were compared. Endpoint was defined as a composite of all-cause death, readmission for heart failure, or left ventricular-assist device implantation. Then, we also investigated correlations between the FIB-4 index and clinical factors, including hemodynamic parameters. Patients with a high FIB-4 index were significantly older (76 [IQR, 63-80] vs. 65 [IQR, 56-74] years, P < 0.001) and had higher right atrial pressure (RAP; 7 [IQR, 5-11] vs. 4 [IQR, 1-6] mmHg, P < 0.001) and pulmonary capillary wedge pressure (16 [IQR, 12-22] vs. 12 [IQR, 8-19] mmHg, P = 0.011) than those with a low FIB-4 index. The FIB-4 index correlated more strongly with parameters of right-sided than left-sided HF (RAP, R = 0.41, P < 0.001; inferior vena cava diameter, R = 0.44, P < 0.001; pulmonary capillary wedge pressure, R = 0.15, P = 0.038; brain natriuretic peptide, R = 0.14, P = 0.29). Multiple regression analysis showed that the FIB-4 index independently correlated with RAP. In conclusion, the FIB-4 index can non-invasively reflect right-sided filling pressure, which might explain why it is associated with a poor prognosis, among patients with heart failure.

Entities:  

Keywords:  Hemodynamics; Liver congestion; Liver fibrosis; Liver stiffness; Residual congestion

Mesh:

Year:  2019        PMID: 31529178     DOI: 10.1007/s00380-019-01505-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  30 in total

1.  Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure.

Authors:  Maria Nikolaou; John Parissis; M Birhan Yilmaz; Marie-France Seronde; Matti Kivikko; Said Laribi; Catherine Paugam-Burtz; Danlin Cai; Pasi Pohjanjousi; Pierre-François Laterre; Nicolas Deye; Pentti Poder; Alain Cohen-Solal; Alexandre Mebazaa
Journal:  Eur Heart J       Date:  2012-10-22       Impact factor: 29.983

2.  Splenomegaly in congestive heart failure.

Authors:  S K Mahajan
Journal:  Indian Heart J       Date:  1971-04

3.  Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.

Authors:  Andrew P Ambrosy; Peter S Pang; Sadiya Khan; Marvin A Konstam; Gregg C Fonarow; Brian Traver; Aldo P Maggioni; Thomas Cook; Karl Swedberg; John C Burnett; Liliana Grinfeld; James E Udelson; Faiez Zannad; Mihai Gheorghiade
Journal:  Eur Heart J       Date:  2013-01-04       Impact factor: 29.983

4.  Liver stiffness is directly influenced by central venous pressure.

Authors:  Gunda Millonig; Stefanie Friedrich; Stefanie Adolf; Hamidreza Fonouni; Mohammad Golriz; Arianeb Mehrabi; Peter Stiefel; Gudrun Pöschl; Markus W Büchler; Helmut Karl Seitz; Sebastian Mueller
Journal:  J Hepatol       Date:  2009-12-04       Impact factor: 25.083

5.  Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.

Authors:  Keisuke Inui; Kuniya Asai; Masaki Tachi; Aya Yoshinaga; Yuki Izumi; Yoshiaki Kubota; Koji Murai; Yayoi Tetsuou Tsukada; Yasuo Amano; Shinichiro Kumita; Wataru Shimizu
Journal:  Heart Vessels       Date:  2018-03-20       Impact factor: 2.037

6.  FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients.

Authors:  Kaku A So-Armah; Joseph K Lim; Vincent Lo Re; Janet P Tate; Chung-Chou H Chang; Adeel A Butt; Cynthia L Gibert; David Rimland; Vincent C Marconi; Matthew B Goetz; Maria C Rodriguez-Barradas; Matthew J Budoff; Hilary A Tindle; Jeffrey H Samet; Amy C Justice; Matthew S Freiberg
Journal:  Hepatology       Date:  2017-08-30       Impact factor: 17.425

7.  Liver stiffness measurements for evaluation of central venous pressure in congenital heart diseases.

Authors:  Zakaria Jalal; Xavier Iriart; Victor De Lédinghen; Thomas Barnetche; Jean-Baptiste Hiriart; Julien Vergniol; Juliette Foucher; Jean-Benoit Thambo
Journal:  Heart       Date:  2015-06-17       Impact factor: 5.994

8.  Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells.

Authors:  Y Kamimoto; S Horiuchi; S Tanase; Y Morino
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

9.  Liver abnormalities in cardiac diseases and heart failure.

Authors:  Alicia M Alvarez; Debabrata Mukherjee
Journal:  Int J Angiol       Date:  2011-09

10.  Dynamics of the liver stiffness value using transient elastography during the perioperative period in patients with valvular heart disease.

Authors:  Young Eun Chon; Seung Up Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Sak Lee
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

View more
  4 in total

1.  A retrospective study on the relationship between fibrosis‑4 index and all‑cause mortality in patients with acute myocardial infarction.

Authors:  Maolin Cao; Tingming Li; Zhifeng Li; Fang Gong; Zijun Chen
Journal:  Exp Ther Med       Date:  2022-08-31       Impact factor: 2.751

2.  Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction.

Authors:  Mitsutaka Nakashima; Satoru Sakuragi; Toru Miyoshi; Shin Takayama; Tatsuto Kawaguchi; Nobuhisa Kodera; Hiroaki Akai; Yuji Koide; Hiroaki Otsuka; Tadashi Wada; Kenji Kawamoto; Machiko Tanakaya; Yusuke Katayama; Hiroshi Ito
Journal:  ESC Heart Fail       Date:  2021-03-24

3.  Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure.

Authors:  Akihiro Shirakabe; Hirotake Okazaki; Masato Matsushita; Yusaku Shibata; Shota Shigihara; Suguru Nishigoori; Tomofumi Sawatani; Nozomi Sasamoto; Kazutaka Kiuchi; Masanori Atsukawa; Norio Itokawa; Taeang Arai; Nobuaki Kobayashi; Kuniya Asai
Journal:  ESC Heart Fail       Date:  2022-03-14

4.  Prognostic value of the liver fibrosis marker fibrosis-5 index in patients with acute heart failure.

Authors:  Daichi Maeda; Yumiko Kanzaki; Kazushi Sakane; Kosuke Tsuda; Kanako Akamatsu; Ryoto Hourai; Takahiro Okuno; Daisuke Tokura; Sayuri Nakayama; Hitomi Hasegawa; Hideaki Morita; Takahide Ito; Masaaki Hoshiga
Journal:  ESC Heart Fail       Date:  2022-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.